Scanning for success: new clue to personalize liver cancer care
NCT ID NCT07449065
Summary
This study looked back at 324 patients with intermediate-stage liver cancer to see if features on a standard CT scan could predict who would live longer. Researchers compared patients who received a standard procedure (TACE) plus a pill (TKI) to those who received the procedure alone. The goal is to find a way to use scans to help doctors choose the right treatment for each patient in the future.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATOCELLULAR CARCINOMA (HCC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Sun Yat-sen University
Guangzhou, Guangdong, 510080, China
Conditions
Explore the condition pages connected to this study.